Nature of the Event
Max Healthcare Institute Limited has made a regulatory disclosure regarding the allotment of equity shares under its Employee Stock Option Scheme 2022.
Key Quantitative Figures
- Number of equity shares allotted: 33,765
- Face value per share: ₹10
- Exercise price per share: ₹350
- Premium per share: ₹340
- Pre-allotment number of equity shares: 97,32,76,486
- Post-allotment number of equity shares: 97,33,10,251
- Pre-allotment paid-up equity capital: ₹973,27,64,860
- Post-allotment paid-up equity capital: ₹973,31,02,510
- Distinctive numbers of allotted shares: 97,32,76,487 to 97,33,10,251 (both inclusive)
Dates of Action
- Allotment date: September 4, 2026
- Committee approval time: 8:52 am (IST) on September 4, 2026
- Initial scheme filing date with exchanges: September 29, 2022
Parties Involved
- Approving authority: Nomination & Remuneration Committee (NRC) of the company
- Recipients: Eligible employees of Max Healthcare Institute Limited
- Stock exchanges: BSE Limited (BSE) and National Stock Exchange of India Limited (NSE)
- Company representative: Dhiraj Aroraa, EVP - Company Secretary and Compliance Officer
Additional Details
- Shares were issued in dematerialized form (no physical certificates)
- No lock-in restrictions apply to the allotted shares
- The new shares are identical in all respects to existing equity shares
- No listing fees are payable for this allotment
- The disclosure will be hosted on the company's website (www.maxhealthcare.in)
Capital Structure Impact
The equity share capital of the company increased by 33,765 shares, resulting in a minimal dilution effect. The paid-up equity capital increased by ₹3,37,650 (33,765 shares × ₹10 face value).
#Tags: #MaxHealthcare #ESOP #SEBIDisclosure #RegulatoryCompliance #CapitalStructure #Neutral